- Home
- ELLO vs ESPR Comparison
ELLO vs ESPR Comparison
Compare ELLO & ESPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELLO
- ESPR
- Stock Information
- Founded
- ELLO 1987
- ESPR 2008
- Country
- ELLO Israel
- ESPR United States
- Employees
- ELLO N/A
- ESPR N/A
- Industry
- ELLO Electric Utilities: Central
- ESPR Biotechnology: Pharmaceutical Preparations
- Sector
- ELLO Utilities
- ESPR Health Care
- Exchange
- ELLO Nasdaq
- ESPR Nasdaq
- Market Cap
- ELLO 208.2M
- ESPR 208.1M
- IPO Year
- ELLO 1995
- ESPR 2013
- Fundamental
- Price
- ELLO $15.30
- ESPR $1.07
- Analyst Decision
- ELLO
- ESPR Buy
- Analyst Count
- ELLO 0
- ESPR 7
- Target Price
- ELLO N/A
- ESPR $5.93
- AVG Volume (30 Days)
- ELLO 2.3K
- ESPR 4.1M
- Earning Date
- ELLO 07-01-2025
- ESPR 08-11-2025
- Dividend Yield
- ELLO N/A
- ESPR N/A
- EPS Growth
- ELLO N/A
- ESPR N/A
- EPS
- ELLO N/A
- ESPR N/A
- Revenue
- ELLO $41,895,641.00
- ESPR $259,574,000.00
- Revenue This Year
- ELLO N/A
- ESPR $4.07
- Revenue Next Year
- ELLO N/A
- ESPR N/A
- P/E Ratio
- ELLO N/A
- ESPR N/A
- Revenue Growth
- ELLO N/A
- ESPR 12.99
- 52 Week Low
- ELLO $11.08
- ESPR $0.69
- 52 Week High
- ELLO $20.81
- ESPR $3.94
- Technical
- Relative Strength Index (RSI)
- ELLO 52.86
- ESPR 51.40
- Support Level
- ELLO $13.18
- ESPR $1.13
- Resistance Level
- ELLO $15.40
- ESPR $1.22
- Average True Range (ATR)
- ELLO 1.04
- ESPR 0.08
- MACD
- ELLO 0.05
- ESPR 0.00
- Stochastic Oscillator
- ELLO 42.35
- ESPR 52.38
About ELLO Ellomay Capital Ltd (Israel)
Ellomay Capital Ltd is focused on the utility sector. It is an Israeli public company, which focuses its business in the energy and infrastructure sectors. The company's operating segment includes Photovoltaic power plants (PV Plants); Dorad Energy Ltd. (Dorad); Groen Gas Goor B.V. and a Pumped storage hydro power plant (Manara). It generates maximum revenue from the Dorad segment. Geographically, it derives a majority of its revenue from Spain.
About ESPR Esperion Therapeutics Inc.
Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.